• Industry News
  • Law & Malpractice
  • Coding & Documentation
  • Practice Management
  • Finance
  • Technology
  • Patient Engagement & Communications
  • Billing & Collections
  • Staffing & Salary

Charging for Blood Draws

Article

We recently started charging patients $20 for blood draws in our office rather than billing the health plan, because reimbursement was so low. We have patients sign a form stating they have a choice between paying the $20 for a blood draw in our office, or being referred to the lab. Response from patients has been enthusiastic; they like the convenience. But a colleague recently pointed out that this may be in violation of our health plan contracts. What do you say? Our small physical space prevents us from having the lab provide a phlebotomist for us.

Question: We recently started charging patients $20 for blood draws in our office rather than billing the health plan, because reimbursement was so low. We have patients sign a form stating they have a choice between paying the $20 for a blood draw in our office, or being referred to the lab. Response from patients has been enthusiastic; they like the convenience. But a colleague recently pointed out that this may be in violation of our health plan contracts. What do you say? Our small physical space prevents us from having the lab provide a phlebotomist for us.

Answer: You’ll have to read your contracts to know for sure, but yes, it could be a problem. Most contracts don’t allow you to charge patients for services already covered under their insurance. In the payers’ eyes, you are asking patients to pay twice - once in the form of the insurance premium and again in cash to your practice.

Remember that if it is a convenience to your patients, providing the service without charging them may be worthwhile despite the low reimbursement from payers. Take a look at your actual costs to make this decision.

Related Videos
The importance of vaccination
The fear of inflation and recession
Protecting your practice
Protecting your home, business while on vacation
Protecting your assets during the 100 deadly days
Payment issues on the horizon
The future of Medicare payments
MGMA comments on automation of prior authorizations
The burden of prior authorizations
Strategies for today's markets
© 2024 MJH Life Sciences

All rights reserved.